Literature DB >> 8118797

Allelotype of head and neck squamous cell carcinoma.

H Nawroz1, P van der Riet, R H Hruban, W Koch, J M Ruppert, D Sidransky.   

Abstract

To gain a better understanding of the molecular changes in head and neck squamous cell carcinoma, we tested every autosomal arm of 29 primary head and neck tumors for allelic loss. Fifty-eight microsatellite markers were used with at least two-thirds of patients informative for each chromosomal arm tested. A high frequency of allelic loss was found on chromosome 9p where 21 of 29 (72%) tumors had loss of heterozygosity for at least one polymorphic marker on this arm. Chromosomes 3, 11q, 13q, and 17p exhibited loss in over 50% of all informative cases, while chromosomes 4, 6p, 8, 14q, and 19q displayed loss in greater than 35% of all cases tested. Additionally, several other chromosomal arms exhibited loss of heterozygosity in 20 to 30% of tumors tested. This high frequency of allelic loss in these advanced stage neoplasms suggests multiple genetic steps in the progression of head and neck cancer and identifies several putative tumor suppressor loci on affected chromosomes.

Entities:  

Mesh:

Year:  1994        PMID: 8118797

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  36 in total

1.  Deletion mapping of chromosome 13q in head and neck squamous cell carcinoma in Indian patients: correlation with prognosis of the tumour.

Authors:  Md Golam Sabbir; Anup Roy; Syamsundar Mandal; Aniruddha Dam; Susanta Roychoudhury; Chinmay Kumar Panda
Journal:  Int J Exp Pathol       Date:  2006-04       Impact factor: 1.925

2.  Recurrent chromosomal imbalances detected in biopsy material from oral premalignant and malignant lesions by combined tissue microdissection, universal DNA amplification, and comparative genomic hybridization.

Authors:  R G Weber; M Scheer; I A Born; S Joos; J M Cobbers; C Hofele; G Reifenberger; J E Zöller; P Lichter
Journal:  Am J Pathol       Date:  1998-07       Impact factor: 4.307

3.  Metastatic variants derived following in vivo tumor progression of an in vitro transformed squamous cell carcinoma line acquire a differential growth advantage requiring tumor-host interaction.

Authors:  Z Chen; C W Smith; D Kiel; C Van Waes
Journal:  Clin Exp Metastasis       Date:  1997-09       Impact factor: 5.150

4.  Inverted sinonasal papilloma : a molecular genetic appraisal of its putative status as a Precursor to squamous cell carcinoma.

Authors:  J Califano; W Koch; D Sidransky; W H Westra
Journal:  Am J Pathol       Date:  2000-01       Impact factor: 4.307

5.  Differences between oral cancer and cancers of the pharynx and larynx on a molecular level.

Authors:  Kiyoto Shiga; Takenori Ogawa; Katsunori Katagiri; Fumiaki Yoshida; Masaru Tateda; Kazuto Matsuura; Toshimitsu Kobayashi
Journal:  Oncol Lett       Date:  2011-10-19       Impact factor: 2.967

6.  Chromosome 3p loss of heterozygosity and mutation analysis of the FHIT and beta-cat genes in squamous cell carcinoma of the head and neck.

Authors:  M V González; M F Pello; P Ablanedo; C Suárez; V Alvarez; E Coto
Journal:  J Clin Pathol       Date:  1998-07       Impact factor: 3.411

7.  Molecular karyotype (amplotype) of metastatic colorectal cancer by unbiased arbitrarily primed PCR DNA fingerprinting.

Authors:  S Malkhosyan; J Yasuda; J L Soto; T Sekiya; J Yokota; M Perucho
Journal:  Proc Natl Acad Sci U S A       Date:  1998-08-18       Impact factor: 11.205

Review 8.  Molecular and cellular biomarkers for field cancerization and multistep process in head and neck tumorigenesis.

Authors:  V A Papadimitrakopoulou; D M Shin; W K Hong
Journal:  Cancer Metastasis Rev       Date:  1996-03       Impact factor: 9.264

Review 9.  Molecular staging of head and neck squamous carcinoma.

Authors:  J A Brennan; D Sidransky
Journal:  Cancer Metastasis Rev       Date:  1996-03       Impact factor: 9.264

10.  Loss of heterozygosity on chromosomes 3p,8p,9p and 17p in the progression of squamous cell carcinoma of the larynx.

Authors:  Woo Jeong Yoo; Seung Ho Cho; Youn Soo Lee; Gyeong Sin Park; Min Sik Kim; Byung Kee Kim; Won Sang Park; Jung Yong Lee; Chang Suk Kang
Journal:  J Korean Med Sci       Date:  2004-06       Impact factor: 2.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.